Vista Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
Particulars | Jun 2024 | Mar 2024 | Dec 2023 |
---|---|---|---|
Revenue | 1.87 | 3.23 | 1.73 |
Operating Expense | 2.57 | 2.87 | 3.45 |
Net Profit | -0.86 | 0.09 | -1.63 |
Net Profit Margin | -45.99 | 2.79 | -94.22 |
Earning Per Share | -0.15 | 0.02 | -0.33 |
EBIDTA | -0.40 | 0.55 | -1.15 |
Effective Tax Rate | TBA | TBA | TBA |
Particulars | Jun 2024 |
---|---|
Revenue | 1.87 |
Operating Expense | 2.57 |
Net Profit | -0.86 |
Net Profit Margin | -45.99 |
Earning Per Share | -0.15 |
EBIDTA | -0.40 |
Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
Total Revenue Annual | 10.29 | 1.00 | 0.39 |
Operating Expenses Annual | 13.60 | 5.45 | 1.66 |
Operating Profit Annual | -3.24 | -4.05 | -1.10 |
Interest Annual | 1.22 | 1.21 | 0.90 |
Depreciation | 0.72 | 0.62 | 0.62 |
Net Profit Annual | -4.51 | -5.66 | -0.89 |
Tax Annual | -0.67 | -0.21 | -1.73 |
Particulars | Mar 2024 |
---|---|
Total Revenue Annual | 10.29 |
Operating Expenses Annual | 13.60 |
Operating Profit Annual | -3.24 |
Interest Annual | 1.22 |
Depreciation | 0.72 |
Net Profit Annual | -4.51 |
Tax Annual | -0.67 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
Cash Flow at the Beginning | 0.20 | 0.07 | 0.14 |
Cash Flow from Operations | -4.91 | -1.71 | -0.99 |
Cash Flow from Investing | -0.79 | -1.27 | -0.01 |
Cash Flow from Financing | 5.59 | 3.11 | 0.94 |
Cash Flow at the End | 0.09 | 0.20 | 0.07 |
Particulars | Mar 2024 |
---|---|
Cash Flow at the Beginning | 0.20 |
Cash Flow from Operations | -4.91 |
Cash Flow from Investing | -0.79 |
Cash Flow from Financing | 5.59 |
Cash Flow at the End | 0.09 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
PBDIT Margin (%) | -31.29 | -392 | -282.05 |
PBIT Margin (%) | -38.29 | -454 | -441.03 |
PBT Margin (%) | -7.39 | -116 | 48.71 |
Net PROFIT Margin (%) | -43.83 | -566 | -228.21 |
Return On Networth / Equity (%) | TBA | TBA | TBA |
Return On Networth /Employed (%) | TBA | TBA | TBA |
Return On Assets (%) | -9.64 | -11.32 | -2.28 |
Total Debt / Equity (X) | 0.23 | 0.31 | 0.34 |
Asset Turnover Ratio (%) | 0.22 | 0.02 | 0.01 |
Particulars | Mar 2024 |
---|---|
PBDIT Margin (%) | -31.29 |
PBIT Margin (%) | -38.29 |
PBT Margin (%) | -7.39 |
Net PROFIT Margin (%) | -43.83 |
Return On Networth / Equity (%) | TBA |
Return On Networth /Employed (%) | TBA |
Return On Assets (%) | -9.64 |
Total Debt / Equity (X) | 0.23 |
Asset Turnover Ratio (%) | 0.22 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
Fixed Assets Annual | 19.32 | 19.74 | 19.33 |
Total Current Assets Annual | 23.40 | 23.75 | 23.56 |
Non Current Assets Annual | 34.58 | 32.28 | 32.03 |
Total Shareholders Funds Annual | 40.46 | 36.71 | 35.45 |
Total Assets Annual | 57.98 | 56.03 | 55.59 |
Particulars | Mar 2024 |
---|---|
Fixed Assets Annual | 19.32 |
Total Current Assets Annual | 23.40 |
Non Current Assets Annual | 34.58 |
Total Shareholders Funds Annual | 40.46 |
Total Assets Annual | 57.98 |
No Data Availabe